Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „ADRs“
Suchtreffer
Begriffe & Kennungen
Altuvoct · 4.8 · Adverse drug reactions (ADRs) (summarized in Table 2) were reported in 111 (40.1%) of the 277 subjects treated
Eintrag öffnenAmeluz · 4.8 · Table 1: Summary of related adverse drug reactions (ADRs) reported in patients treated with photodynamic thera
Eintrag öffnenAripiprazole Sandoz · 4.8 · All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), unc
Eintrag öffnenAripiprazole Sandoz · 4.8 · The incidences of the Adverse Drug Reactions (ADRs) associated with aripiprazole therapy are tabulated below.
Eintrag öffnenBetaferon · 4.8 · Table 1: Adverse drug reactions (ADRs) based on reports from clinical trials and identified during post-market
Eintrag öffnenCabometyx · 4.8 · Table 2: Adverse drug reactions (ADRs) reported in clinical trials or after post-marketing use in patients tre
Eintrag öffnenCalquence · 4.8 · Of the 1 478 patients treated with Calquence monotherapy, the most common (≥ 20%) adverse drug reactions (ADRs
Eintrag öffnenCalquence · 4.8 · Of the 1 478 patients treated with Calquence monotherapy, the most common (≥ 20%) adverse drug reactions (ADRs
Eintrag öffnenCalquence · 4.8 · Of the 223 patients treated with Calquence in combination with obinutuzumab, the most common (≥ 20%) ADRs of a
Eintrag öffnenCalquence · 4.8 · Of the 223 patients treated with Calquence in combination with obinutuzumab, the most common (≥ 20%) ADRs of a
Eintrag öffnenCalquence · 4.8 · Of the 291 patients treated with Calquence in combination with venetoclax, the most common (≥ 20%) ADRs of any
Eintrag öffnenCalquence · 4.8 · Of the 291 patients treated with Calquence in combination with venetoclax, the most common (≥ 20%) ADRs of any
Eintrag öffnenCalquence · 4.8 · The below tables present adverse drug reactions (ADRs) identified in clinical studies with patients receiving
Eintrag öffnenCalquence · 4.8 · The below tables present adverse drug reactions (ADRs) identified in clinical studies with patients receiving
Eintrag öffnenCapecitabine Accord · 4.8 · 15 Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensor
Eintrag öffnenCapecitabine Accord · 4.8 · ADRs considered by the investigator to be possibly, probably, or remotely related to the administration of cap
Eintrag öffnenCapecitabine Accord · 4.8 · Capecitabine in combination therapy Table 6 lists ADRs associated with the use of capecitabine in combination
Eintrag öffnenCapecitabine Accord · 4.8 · Capecitabine monotherapy Table 5 lists ADRs associated with the use of capecitabine monotherapy based on a poo
Eintrag öffnenCapecitabine Accord · 4.8 · Cardiotoxicity (see section 4.4) In addition to the ADRs described in tables 4 and 5, the following ADRs with
Eintrag öffnenCapecitabine Accord · 4.8 · Encephalopathy In addition to the ADRs described in tables 4 and 5, and based on the above pooled analysis fro
Eintrag öffnen